
OpenEvidence Funding Doubt Exposes $20B AI Dilemma
OpenEvidence may skip a $200M raise at a $20B valuation as fast growth and breakeven cash flow make dilution hard to justify.
Tag archive

OpenEvidence may skip a $200M raise at a $20B valuation as fast growth and breakeven cash flow make dilution hard to justify.

Emergent raised $130M at a $1.5B valuation after hitting $120M in annualized revenue and 200,000 paying customers.

Oratomic raised $300M to chase a useful quantum computer with 10,000 to 20,000 qubits, challenging million-qubit roadmaps.

Originally published at norvik.tech Introduction Explore the implications of Chamath...

Twelve Labs raised $100M to scale video AI models that search, index, and reason over footage instead of text alone.

Private fusion funding has hit $7.1B, but the real fight is over which reactor design can become a bankable power plant.

Baseten could raise $1.5B at a $13B valuation, turning AI inference into one of VC’s hottest infrastructure bets.
AI music generator Suno raised another $400M while still fighting copyright lawsuits. Here's what that funding-versus-legal gap means for Sri Lankan creators.
30% of pet tech startups hit hidden scaling walls. I unpack the five moves that turned Gr3n into a €15.5M powerhouse—and how you can apply them to fast‑track yo
Spellbook's Scott Stevenson calls out widespread ARR inflation in AI sector, threatening investor confidence and valuations.
AI-Powered Design Tools Target Production Integration Dessn, an emerging startup in the...
Insurtech startups are commanding record investment rounds in 2026 despite a shrinking pipeline, with median deal sizes climbing to $10 million according to CB Insights analysis.